Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study

Jaana Ronkainen1, Marja Ala-Houhala, Helena Autio-Harmainen

  • 1Department of Pediatrics and Adolescence, Oulu University Hospital, P.O. Box 23, 90029, Oulu, Finland. Matti.Nuutinen@ppshp.fi

Insights

Childhood IgA nephritis can lead to long-term kidney problems, including end-stage renal disease (ESRD). Adults who had childhood IgA nephritis often experience persistent symptoms and require ongoing management, particularly during pregnancy.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Internal Medicine

Background:

  • Childhood IgA nephritis (IgAN) is a common glomerular disease.
  • Long-term outcomes and prognostic factors for IgAN in childhood are not fully understood.
  • Adult follow-up is crucial for managing potential long-term complications.

Purpose of the Study:

  • To evaluate the natural long-term outcome of childhood IgA nephritis.
  • To identify predictive factors for persistent nephropathy or end-stage renal disease (ESRD).
  • To assess the impact of childhood IgA nephritis on adult health, including pregnancy outcomes.

Main Methods:

  • Retrospective analysis of 55 patients with biopsy-proven childhood IgA nephritis.
  • Follow-up included health questionnaires, medical examinations, and review of medical histories and national kidney registry data.
  • Analysis of original kidney biopsy findings (chronicity index, total biopsy score) and patient demographics (age at diagnosis).

Main Results:

  • 11% of patients developed ESRD after a mean follow-up of 18.7 years.
  • 71% experienced renal symptoms, and 39% were treated for hypertension/proteinuria in adulthood.
  • Higher chronicity index and total biopsy score in initial biopsies predicted persistent nephropathy or ESRD.
  • Patients diagnosed over 16 years old had a significantly higher risk (RR 3.1) of persistent nephropathy or ESRD.
  • Pregnancy complications (proteinuria, hypertension) occurred in 55% of pregnancies, with a 30% prematurity rate.

Conclusions:

  • Childhood IgA nephritis can have significant long-term consequences into adulthood.
  • Early kidney biopsy findings are predictive of long-term renal outcomes.
  • Adolescent and adult patients, especially females during pregnancy, require vigilant long-term monitoring and management.
  • Even seemingly mild childhood IgA nephritis necessitates lifelong follow-up.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...